Agilon Health (AGL) Shares Outstanding (Weighted Average) (2020 - 2026)

Agilon Health has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $16.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.5% year-over-year to $16.6 million; the trailing twelve-month figure through Mar 2026 stood at $16.6 million (changed 0.5% YoY), and the FY2025 full-year result was $414.0 million, up 0.73% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $16.6 million, down from $414.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $414.5 million in Q3 2025, with the low at $16.5 million in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $363.4 million across 5 years, with a median of $409.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) rose 23.43% — and 2025, when it sank 95.96%.
• Agilon Health's Shares Outstanding (Weighted Average) stood at $408.2 million in 2022, then grew by 0.19% to $408.9 million in 2023, then rose by 0.5% to $411.0 million in 2024, then increased by 0.73% to $414.0 million in 2025, then plunged by 95.99% to $16.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $16.6 million (Q1 2026), $414.0 million (Q4 2025), and $414.5 million (Q3 2025), per Business Quant data.